Lee Financial CO Biogen Inc. Transaction History

Lee Financial CO

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 08, 2024	SELL	$222.59 - $267.94 $1,335 - $1,607	-6 Reduced 75.0%	2 $0
Q1 2023 May 15, 2023	SELL	$256.56 - $292.34 $513 - $584	-2 Reduced 20.0%	8 $2,000
Q3 2022 Nov 01, 2022	BUY	$194.69 - $268.46 $1,557 - $2,147	8 Added 400.0%	10 $3,000
Q2 2022 Aug 10, 2022	BUY	$187.54 - $223.02 $375 - $446	2 New	2 $0
Q3 2021 Nov 12, 2021	SELL	$282.99 - $369.05 $2,263 - $2,952	-8 Closed	0 $0
Q2 2021 Aug 04, 2021	BUY	$259.0 - $414.71 $2,072 - $3,317	8 New	8 $3,000
Q1 2020 May 07, 2020	SELL	$268.85 - $341.04 $4,839 - $6,138	-18 Closed	0 $0
Q1 2019 Apr 30, 2019	BUY	$216.71 - $338.96 $3,900 - $6,101	18 New	18 $4,000
Q3 2018 Nov 07, 2018	SELL	$293.51 - $383.83 $2,935 - $3,838	-10 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$257.52 - $306.91 $2,317 - $2,762	9 Added 900.0%	10 $3,000
Q1 2018 May 09, 2018	BUY	$260.13 - $367.91 $260 - $367	1 New	1 $0

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Lee Financial CO, based on Form 13F filings with the SEC.

Stay updated on Lee Financial CO with notifications on news.